Skip to main content
Clinical Trials/PACTR201905784271304
PACTR201905784271304CompletedPhase 3

Fast and reliable easy-to-use-diagnostics for eliminating Bilharzia in young children and mothers (freeBILy)

Bernhard Nocht Institute of Tropical Medicine0 sites5,200 target enrollmentStarted: April 4, 2019Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
5,200

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
0 Month(s) to 23 Month(s) (—)
Sex
All

Inclusion Criteria

  • Informed consent signed (from the parents for minors)
  • - Expected residency in the area of the study site for the next 24 months
  • - Pregnant women between their 5th and 6th months of pregnancy
  • - Children born from an enrolled mother, including twins
  • - Willingness to comply with the protocol requirements including: sampling and treatment for
  • both mothers and children

Exclusion Criteria

  • - Fever (temporary exclusion)
  • - History of transfusion
  • - History of congenital anaemia
  • - Epileptic or convulsive episodes
  • - Non-pregnant women
  • - Pregnant women younger than 16 years old
  • - Pregnant women who have not completed their 4th month of pregnancy
  • - Pregnant women over their 6th month of pregnancy
  • - Pregnant women who do not live in the area of the CSB
  • - Children born from mothers not enrolled in the study
  • - Children born in a CSB different from the ones in which the mothers were enrolled

Investigators

Sponsor
Bernhard Nocht Institute of Tropical Medicine

Similar Trials